You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

Litigation Details for ADAMAS PHARMA, LLC v. SANDOZ INC. (D.N.J. 2018)

✉ Email this page to a colleague

« Back to Dashboard

ADAMAS PHARMA, LLC v. SANDOZ INC. (D.N.J. 2018)

Docket	⤷ Sign Up	Date Filed	2018-05-10
Court	District Court, D. New Jersey	Date Terminated	2020-01-06
Cause	15:1126 Patent Infringement	Assigned To	Brian R. Martinotti
Jury Demand	None	Referred To	Tonianne J. Bongiovanni
Parties	SANDOZ INC.
Patents	6,913,768; 6,919,373; 8,039,009; 8,058,291; 8,168,209; 8,173,708; 8,252,331; 8,283,379; 8,293,794; 8,329,752; 8,338,485; 8,338,486; 8,362,085; 8,389,578; 8,574,626; 8,580,858; 8,598,233; 8,741,343; 8,796,337; 8,889,740; 8,895,614; 8,895,615; 8,895,616; 8,895,617; 8,895,618; 9,867,791; 9,867,792; 9,867,793; 9,877,933
Attorneys	CHARLES MICHAEL LIZZA
Firms	Eric I. Abraham
Link to Docket	External link to docket

Small Molecule Drugs cited in ADAMAS PHARMA, LLC v. SANDOZ INC.

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Details for ADAMAS PHARMA, LLC v. SANDOZ INC. (D.N.J. 2018)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2018-05-10	1	Complaint	between 200 mg and example, by U.S. Pat. No. 6,913,768, hereby incorporated by 400 mg per… 45 example, by U.S. Pat. No. 6,913,768, hereby incorporated by antagonist or the levodopa… example, by U.S. Pat. No. 6,913,768, hereby incorporated by antagonist or the levodopa…preferably between 200 example, by U.S. Pat. No. 6,913,768, hereby incorporated by mg and 600… 45 example, by U.S. Pat. No. 6,913,768, hereby incorporated by antagonist or the levodopa	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.